Medicines Discovery Catapult has joined forces with Cystic Fibrosis Trust to form the Cystic Fibrosis (CF) Antimicrobial Resistance (AMR) Syndicate. The CF AMR Syndicate brings industry leaders and people with CF together with academics with expertise in CF and pulmonary infection.
Join our Network
The CF AMR Network will facilitate collaboration and knowledge exchange in CF infection research.
Our aim is to create a diverse cross-sector collaborative network, with the expertise and drive required to drive and accelerate CF antimicrobial development.